These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15328815)

  • 1. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
    Yuan CS
    J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ; Yuan CS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
    Yuan CS
    Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
    J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.
    Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone: MNTX.
    Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
    Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
    J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylnaltrexone (Relistor) for opioid induced constipation.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):63-4. PubMed ID: 18688204
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
    Lee JM; Mooney J
    Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.
    Slatkin NE; Lynn R; Su C; Wang W; Israel RJ
    J Pain Symptom Manage; 2011 Nov; 42(5):754-60. PubMed ID: 22045373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
    Shaiova L; Rim F; Friedman D; Jahdi M
    Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone for the treatment of opioid-induced constipation.
    Bader S; Dürk T; Becker G
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
    Portenoy RK; Thomas J; Moehl Boatwright ML; Tran D; Galasso FL; Stambler N; Von Gunten CF; Israel RJ
    J Pain Symptom Manage; 2008 May; 35(5):458-68. PubMed ID: 18440447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
    Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.